India has been witnessing the shortage of medical oxygen and the lack of availability of vaccines.
People are very much concerned about it and have been looking for the measures of the central government.
Amid, the rising deaths due to medical oxygen shortage , India’s Defence Research and Development Organisation or the DRDO had developed a new anti-COVID-19 oral drug called 2-deoxy-D-glucose (2-DG).
The DRDO has expressed confidence that the drug will help patients to reduce their dependency on medical oxygen.
Covid-19 news: Do you still need an Oximeter if you have a smartwatch with SpO2 sensor?
